Hypothesis

Chronic low‑grade neuroinflammation elevates mitochondrial reactive oxygen species (ROS) selectively in Von Economo neurons (VENs), triggering TDP‑43 phosphorylation and tauopathy that drives their early degeneration in behavioral variant frontotemporal dementia (bvFTD).

Mechanistic Rationale

VENs are exceptionally large, sparsely myelinated projection neurons with high basal metabolic demand to sustain long‑range afferent/efferent signaling [[https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.074575]]. Their extensive dendrites and axons increase surface area for mitochondrial activity, making them vulnerable to ROS overload. Inflammatory cytokines (e.g., IL‑1β, TNF‑α) released by activated microglia enhance NADPH oxidase activity and impair complex I of the electron transport chain, raising superoxide production specifically in VENs [[https://www.news-medical.net/news/20250810/Special-von-Economo-neurons-may-hold-key-to-super-sharp-memory-in-802b-superagers.aspx]]. Elevated ROS promotes oxidative modification of TDP‑43, favoring its cytoplasmic aggregation and subsequent seeding of tau hyperphosphorylation, a cascade observed in FTD‑linked proteinopathies [[https://academic.oup.com/cercor/article/22/2/251/333630]]. Because Alzheimer’s disease pathology primarily targets amyloid‑β pathways without the same inflammatory burst in the frontoinsular cortex, VENs remain relatively spared there [[https://academic.oup.com/cercor/article/22/2/251/333630]]. Superagers, who exhibit low microglial activation and preserved VEN density, likely maintain mitochondrial redox balance, supporting the idea that inflammation‑ROS is a modifiable driver [[https://www.news-medical.net/news/20250810/Special-von-Economo-neurons-may-hold-key-to-super-sharp-memory-in-802b-superagers.aspx]].

Testable Predictions

1. In post‑mortem bvFTD tissue, VENs will show higher mitochondrial ROS markers (e.g., oxidized cytochrome c, 8‑OH‑dG) compared to neighboring layer 5 pyramidal neurons, while AD tissue will not differ.
2. Exposing human iPSC‑derived VEN‑like organoids to IL‑1β/TNF‑α will increase mitochondrial superoxide, induce TDP‑43 phosphorylation, and reduce VEN‑specific marker expression (e.g., FOXP2) without affecting total neuron count.
3. Pharmacological scavenging of mitochondrial ROS (e.g., MitoQ) in the organoid model will rescue VEN density and attenuate TDP‑43/tau pathology despite continued cytokine exposure.
4. In living participants, elevated plasma IL‑6 will correlate with lower interoceptive accuracy (heartbeat detection task) and reduced anterior cingulate VEN‑derived fMRI signal, preceding clinical bvFTD symptoms by ≥2 years.

Experimental Approach

• Human tissue: Multiplex immunofluorescence on frontoinsular cortex sections from bvFTD, AD, and control brains (n ≥ 15 per group) to quantify VEN‑specific ROS (MitoSOX), 8‑OH‑dG, p‑TDP‑43, and AT8 tau; statistical comparison via ANOVA with post‑hoc Tukey.
• iPSC organoids: Generate cortical organoids enriched for deep‑layer VEN‑like neurons using FOXP2 overexpression; treat with cytokine cocktail (IL‑1β + TNF‑α, 10 ng mL⁻¹ each) for 14 days; assess mitochondrial ROS (MitoSOX flow cytometry), TDP‑43 solubility (Western blot), and VEN marker loss (immunostaining). Parallel wells receive MitoQ (500 nM).
• In vivo biomarker: Recruit 120 cognitively normal adults aged 55‑80; measure plasma IL‑6, perform heartbeat tracking interoceptive task, and acquire high‑resolution 7 T fMRI to extract anterior cingulate BOLD variability linked to VEN networks. Follow for 3 years; use Cox regression to test whether baseline IL‑6 predicts conversion to bvFTD mediated by interoceptive decline.

If ROS elevation is specific to VENs in inflammatory contexts and its reduction rescues pathology, the hypothesis is supported; lack of ROS differences or failure of antioxidants to protect VENs would falsify it.